Snapshots from There and Then: History of Homeopathy
In honor of AAHP’s 100th anniversary year, we’re looking back at the history of homeopathy to learn how the medical modality spread worldwide. Readers will discover startling vignettes of unexpected…
Read MoreCompliance Makes All the Difference
By Mark Land, M.S., RAC, AAHP President The May issue of the AAHP newsletter examined the work of the Federal Trade Commission (FTC) while this issue examines the Food and…
Read MoreMeet HPCUS President William Shevin
Published since 1897, the Homeopathic Pharmacopoeia of the United States (HPUS) provides a clear set of standards and guidelines for the manufacturer of homeopathic drug products. Since 1980, the HPUS has been…
Read MoreRevised HPUS Website to Launch in June
By Eric L. Foxman, Senior Scientist, HPCUS The revised and updated HPUS.com for the Homeopathic Pharmacopeia of the United States will tentatively be launched June 5. The newly designed website will continue to be…
Read MoreSnapshots From There and Then: History of Homeopathy
In honor of AAHP’s 100th anniversary year, we’re looking back at the history of homeopathy to learn how the medical modality spread worldwide. Readers will discover startling vignettes of unexpected…
Read MoreThe HPCUS Friends of the Pharmacopoeia Program
By Dr. William Shevin, President, HPCUS Due to challenges in general for homeopathy and specifically for the Homeopathic Pharmacopoeia Convention of the United States (HPCUS), the standards-setting organization is launching…
Read MoreFTC Notices of Penalty Offenses: What Should You Do?
By Mark Land, M.S., RAC, AAHP President Most of you have probably seen media mentions about almost 700 “Notices of Penalty Offenses” sent by the Federal Trade Commission (FTC) to…
Read MoreIn Conversation with Homeopathic Industry Veteran J.P. Borneman
Dr. John “Jay” Borneman was born into the field of homeopathy. His great-grandfather, grandfather, and father paved the way before him through their own extensive and impressive careers in the…
Read MoreWhat’s In a Name?
By Al Lorman, AAHP Counsel FDA’s issuance of its new guidance on homeopath drugs in December, 2022 has caused concern in some quarters because of the language used by the…
Read MoreA Retrospective Policy Analysis of FDA’s CPG 400.400
The origins of FDA’s CPG 400.400 go back to a series of meetings between industry and Agency enforcement personnel in the 1980s. The resulting CPG was unusual in that many…
Read More